Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 50,711,000 | 49,776,000 | 48,891,000 | 45,442,000 | 45,106,000 |
| Cost of Goods | 43,520,000 | 41,999,000 | 40,295,000 | 39,512,000 | 38,042,000 |
| Gross Profit | 7,191,000 | 7,777,000 | 8,596,000 | 5,930,000 | 7,064,000 |
| Operating Expenses | 5,434,000 | 5,144,000 | 5,455,000 | 4,984,000 | 5,391,000 |
| Operating Income | 1,757,000 | 2,633,000 | 3,141,000 | 946,000 | 1,673,000 |
| Interest Expense | 351,000 | 341,000 | 344,000 | 340,000 | 300,000 |
| Pre-tax Income | 1,406,000 | 2,292,000 | 2,797,000 | 606,000 | 1,373,000 |
| Income Tax | 219,000 | 548,000 | 613,000 | 193,000 | 365,000 |
| Net Income Continuous | 1,187,000 | 1,744,000 | 2,184,000 | 413,000 | 1,008,000 |
| Minority Interests | -2,000 | 1,000 | 1,000 | -5,000 | -8,000 |
| Net Income | $1,189,000 | $1,743,000 | $2,183,000 | $418,000 | $1,016,000 |
| EPS Basic Total Ops | 5.32 | 7.74 | 9.64 | 1.87 | 4.38 |
| EPS Basic Continuous Ops | 5.32 | 7.74 | 9.65 | 1.85 | 4.35 |
| EPS Diluted Total Ops | 5.32 | 7.72 | 9.61 | 1.88 | 4.36 |
| EPS Diluted Continuous Ops | 5.31 | 7.72 | 9.61 | 1.85 | 4.32 |
| EPS Diluted Before Non-Recurring Items | 6.03 | 8.84 | 11.97 | 3.84 | 8.37 |
| EBITDA(a) | $2,144,000 | $3,013,000 | $3,514,000 | $1,344,000 | $2,002,000 |